» Articles » PMID: 32945492

Characterization of a Novel Mutation in the MYOC Gene in a Chinese Family with Primary Open‑angle Glaucoma

Overview
Journal Mol Med Rep
Specialty Molecular Biology
Date 2020 Sep 18
PMID 32945492
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Although primary open‑angle glaucoma (POAG)‑related mutations in the myocilin (MYOC) gene have been reported, the underlying associations remain poorly understood. In the present study, the relationship between a MYOC mutation and POAG was investigated using ophthalmic examination and total exon gene sequencing in a Chinese family comprised of 5 individuals with POAG and 15 unaffected individuals. Pathogenic mutations underlying POAG were identified by whole‑exome sequencing and subsequently validated by Sanger sequencing. Of the family members, nine (45%) harbored heterozygous p.D208Y mutations; among these, five had POAG and four were unaffected. The mean age at diagnosis was 26.2±4.12 years and the mean intraocular pressure (IOP) was 39.7±16.58 mmHg; all affected members complained of vision loss, headaches and eye swelling. Among the five cases of POAG, two presented with blindness. Among 10 members of the family who underwent comprehensive ophthalmologic examination, 3 individuals exhibited severe visual field defects. The mean age at the time of operation was 27.2±3.54 years. In the present study, a novel MYOC mutation (c.G622T: p.D208Y) was identified that was associated with severe visual impairment, high IOP and the need for frequent surgical interventions. Some carriers of the mutation were young and did not show signs of glaucoma. These individuals should be followed‑up to firmly establish whether the mutated gene is pathogenic for POAG.

Citing Articles

Case Report: Reversal and subsequent return of optic disc cupping in a myocilin (MYOC) gene-associated severe Juvenile Open-Angle Glaucoma (JOAG) patient.

El Helwe H, Samuel S, Gupta S, Neeson C, Chachanidze M, Sola-Del Valle D F1000Res. 2024; 11:1361.

PMID: 38868171 PMC: 11167334. DOI: 10.12688/f1000research.127871.1.


Genetics and Glaucoma: the state of the art.

Tirendi S, Domenicotti C, Bassi A, Vernazza S Front Med (Lausanne). 2023; 10:1289952.

PMID: 38152303 PMC: 10751926. DOI: 10.3389/fmed.2023.1289952.


Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?.

Belamkar A, Harris A, Oddone F, Verticchio Vercellin A, Fabczak-Kubicka A, Siesky B J Clin Med. 2022; 11(9).

PMID: 35566612 PMC: 9099679. DOI: 10.3390/jcm11092486.

References
1.
Susanna Jr R, Vessani R . Staging glaucoma patient: why and how?. Open Ophthalmol J. 2009; 3:59-64. PMC: 2760888. DOI: 10.2174/1874364100903020059. View

2.
Quigley H . Glaucoma. Lancet. 2011; 377(9774):1367-77. DOI: 10.1016/S0140-6736(10)61423-7. View

3.
Yang H, Robinson P, Wang K . Phenolyzer: phenotype-based prioritization of candidate genes for human diseases. Nat Methods. 2015; 12(9):841-3. PMC: 4718403. DOI: 10.1038/nmeth.3484. View

4.
Wang K, Li M, Hakonarson H . ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010; 38(16):e164. PMC: 2938201. DOI: 10.1093/nar/gkq603. View

5.
Zhou M, Wang W, Huang W, Zhang X . Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. PLoS One. 2014; 9(8):e102972. PMC: 4138056. DOI: 10.1371/journal.pone.0102972. View